CLORAZEPATE DIPOTASSIUM — all Canadian products
9 DINs
3 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is CLORAZEPATE DIPOTASSIUM, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 00860700 | CLORAZEPATE | AA PHARMA INC | Capsule | Oral | CLORAZEPATE DIPOTASSIUM 7.5 MG | Marketed | |
| 00860697 | CLORAZEPATE | AA PHARMA INC | Capsule | Oral | CLORAZEPATE DIPOTASSIUM 15 MG | Marketed | |
| 00860689 | CLORAZEPATE | AA PHARMA INC | Capsule | Oral | CLORAZEPATE DIPOTASSIUM 3.75 MG | Marketed | |
| 00628212 | NOVO-CLOPATE CAP 15MG | NOVOPHARM LIMITED | Capsule | Oral | CLORAZEPATE DIPOTASSIUM 15 MG | Cancelled Post Market | |
| 00628190 | NOVO-CLOPATE CAP 3.75MG | NOVOPHARM LIMITED | Capsule | Oral | CLORAZEPATE DIPOTASSIUM 3.75 MG | Cancelled Post Market | |
| 00628204 | NOVO-CLOPATE CAP 7.5MG | NOVOPHARM LIMITED | Capsule | Oral | CLORAZEPATE DIPOTASSIUM 7.5 MG | Cancelled Post Market | |
| 00264911 | TRANXENE CAP 15MG | ABBOTT LABORATORIES, LIMITED | Capsule | Oral | CLORAZEPATE DIPOTASSIUM 15 MG | Cancelled Post Market | |
| 00264938 | TRANXENE CAP 3.75MG | ABBOTT LABORATORIES, LIMITED | Capsule | Oral | CLORAZEPATE DIPOTASSIUM 3.75 MG | Cancelled Post Market | |
| 00264946 | TRANXENE CAP 7.5MG | ABBOTT LABORATORIES, LIMITED | Capsule | Oral | CLORAZEPATE DIPOTASSIUM 7.5 MG | Cancelled Post Market |
Browse other molecules: